Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01596023 · ClinicalTrials.gov registry record · NA
Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients
A NA study, sponsored by Breathe Technologies.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01596023 is a NA study that has completed, run by Breathe Technologies. The registered enrollment target is 14 participants.
The verdict
NCT01596023, a NA study, has completed, sponsored by Breathe Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The Breathe Ventilator is a lightweight, wearable ventilator that has received U.S. FDA clearance for use in patients with respiratory difficulty. The investigators believe that the Breathe NIOV system will reduce the work of the diaphragm and breathing by providing added tidal volume and oxygen. This will be a study in 14 patients with severe-to-very severe chronic obstructive lung disease (COPD) to assess their work of breathing while using the NIOV system as measured by esophageal and stomach pressures.
Interventions
- DEVICE Breathe NIOV Ventilator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01596023
The ClinicalTrials.gov registry entry for NCT01596023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Breathe Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breathe NIOV Ventilator is the first listed.
NCT01596023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01596023 about?
NCT01596023 is a clinical study titled "Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients". The Breathe Ventilator is a lightweight, wearable ventilator that has received U.S. FDA clearance for use in patients with respiratory difficulty. The investigators believe that the Breathe NIOV system will reduce the work of the diaphragm and breathing by providing added tidal volume and oxygen. Th...
What is the current status of trial NCT01596023?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2012-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01596023?
The interventions under investigation include: Breathe NIOV Ventilator (DEVICE).
Who is sponsoring clinical trial NCT01596023?
This trial is sponsored by Breathe Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.